Skip to content

Subcutaneous Drain Versus Wound Irrigation by Normal Saline for Prevention of Surgical Site Infection Following Caesarean Section in Obese Patients.

Subcutaneous Drain Versus Wound Irrigation by Normal Saline for Prevention of Surgical Site Infection Following Caesarean Section in Obese Patients: A Prospective Randomized Controlled Trial.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07517718
Enrollment
189
Registered
2026-04-08
Start date
2025-01-09
Completion date
2025-11-01
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean Section Wound, Surgical Site Infection (SSI)

Brief summary

This is a prospective randomized controlled trial conducted at Ain Shams University Maternity Hospital to compare subcutaneous drain versus wound irrigation with normal saline for the prevention of surgical site infection following cesarean section in obese patients. Eligible women were randomly assigned to either subcutaneous drain placement or intraoperative wound irrigation, or subcutaneous skin closure only. The primary outcome was the incidence of surgical site infection, with additional assessment of postoperative wound complications and recovery.

Interventions

Subcutaneous Drain is put before wound closure

PROCEDURENormal Saline

wound irrigation with Normal Saline before wound closure

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Obese Pregnant women who attend for cesarean section. * Aged 18 to 50 years old. * BMI ≥ 30 kg/m2.

Exclusion criteria

* Preoperative uncontrolled infection. * Prolonged premature rupture of membranes. * Severe surgical blood loss \>1000ml. * Uncontrolled Pregestational Diabetes mellitus type 1 and type2. * Uncontrolled Gestational Diabetes mellitus. * Uncontrolled Hypertension with pregnancy. * Preeclampsia and Eclampsia, Pregnancy-induced hypertension (PIH). * Chronic medical disorders including chronic kidney disease, chronic hepatitis, chronic autoimmune disease and chronic heart disease. * Anemia with pregnancy. * Patient with Immunodeficiency disorders and patients on immunosuppressive drugs. * Patient with recent history of drug abuse. * Smoker.

Design outcomes

Primary

MeasureTime frameDescription
Incidence of surgical site infection10 daysAssessment of surgical site infection according to standard clinical criteria following cesarean section in the study groups.

Secondary

MeasureTime frameDescription
Wound complications6 weeksDehiscence of wound, cosmetic evaluation, need for surgical intervention.

Countries

Egypt

Contacts

PRINCIPAL_INVESTIGATORMahmoud M. Ghaleb

Department of Obstetrics and Gynecology, faculty of Medicine, Ain Shams University

PRINCIPAL_INVESTIGATORWaleed H. Ahmed

Department of Obstetrics and Gynecology, faculty of Medicine, Ain Shams University

PRINCIPAL_INVESTIGATORMohammad A. Alzeiny

Department of Obstetrics and Gynecology, faculty of Medicine, Ain Shams University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 15, 2026